Luteolin ameliorates colistin-induced nephrotoxicity in the rat models

dc.authorid0000-0002-4557-9517
dc.contributor.authorArslan, Birsen Yigit
dc.contributor.authorArslan, Ferhat
dc.contributor.authorErkalp, Kerem
dc.contributor.authorAlagol, Aysin
dc.contributor.authorSevdi, Mehmet Salih
dc.contributor.authorYildiz, Gunes
dc.contributor.authorKucuk, Suat Hayri
dc.date.accessioned2025-05-10T19:45:02Z
dc.date.issued2016
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractIntroduction and aim: To study the protective, preventive effect of luteolin from colistin-induced nephrotoxicity.Material and method: Four different treatment options were tested on rats: colistin, luteolin, and a combination of colistin and luteolin, intraperitoneally as two doses a day, for seven days. Another group of rats were used as the control and treated with sterile saline. Serum creatinine levels were measured before and after treatment. Histological changes and colistin-induced apoptosis (Insitu BrdU-red DNA Fragmentation Assay Kit) of the renal tissues were examined after the scarification procedure.Results: In the Colistin Group, post-treatment creatinine levels were statistically higher than the pretreatment levels (p=.001). In the remaining groups, no significant changes were observed. Cells that undergo apoptosis were counted and it was shown that all groups except the colistin-treated group had a similar number of apoptotic cells, whereas the colistin-treated group had statistically higher number of apoptotic cells compared to other groups (p=.0001). Renal histological damage was also measured and the score of the colistin treated group was higher as compared to other groups.Conclusion: The results obtained from this study demonstrated us that luteolin was capable of preventing colistin-induced nephrotoxicity and that this effect was significant at histopathological level.
dc.description.sponsorshipBagcilar Training and Research Hospital [2014-24]
dc.description.sponsorshipColistimethate sodium was provided from Kocak Farma Pharmaceutical Company free of charge. Supported by a grant (2014-24) Bagcilar Training and Research Hospital.
dc.identifier.doi10.1080/0886022X.2016.1229995
dc.identifier.endpage1740
dc.identifier.issn0886-022X
dc.identifier.issn1525-6049
dc.identifier.issue10
dc.identifier.pmid27764981
dc.identifier.scopus2-s2.0-84992130184
dc.identifier.scopusqualityQ2
dc.identifier.startpage1735
dc.identifier.urihttps://doi.org/10.1080/0886022X.2016.1229995
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11124
dc.identifier.volume38
dc.identifier.wosWOS:000392430900025
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofRenal Failure
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectFlavonoid
dc.subjectcolistin
dc.subjectnephrotoxicity
dc.titleLuteolin ameliorates colistin-induced nephrotoxicity in the rat models
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
11124.pdf
Boyut:
1.48 MB
Biçim:
Adobe Portable Document Format